SEC Info - Opexa Therapeutics, Inc. - ‘8-K’ for 9/28/15

SEC Info℠

Home

Help

Please Sign In

Opexa Therapeutics, Inc. – ‘8-K’ for 9/28/15

On: Monday, 9/28/15, at 7:02am ET · For: 9/28/15 · Accession #: 1354488-15-4388 · File #: 1-33004

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 9/28/15  Opexa Therapeutics, Inc.          8-K:3,5,8,9 9/28/15    3:56K                                    Issuer Direct/FA

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     22K 
 2: EX-3.1      Certificate of Amendment                            HTML     10K 
 3: EX-99.1     Press Release                                       HTML     11K

Filing Submission 0001354488-15-004388 – SGML Text

Original SGML Text submitted by:	Issuer Direct/FA (as Filing Agent)

⇓Show all <DOCUMENT> <TEXT> elements below – 56K ↑Top ↓Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20150928-070322	 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20150928-070322	 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20150928-070243	 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0001354488-15-004388
<TYPE>				8-K
<PUBLIC-DOCUMENT-COUNT>		3
<PERIOD>			20150928
<ITEMS>				3.03
<ITEMS>				5.03
<ITEMS>				8.01
<ITEMS>				9.01
<FILING-DATE>			20150928
<DATE-OF-FILING-DATE-CHANGE>	20150928

<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>		Opexa Therapeutics, Inc.
<CIK>				0001069308
<ASSIGNED-SIC>			2834
<IRS-NUMBER>			760333165  ⇒ 76-0333165
<STATE-OF-INCORPORATION>	TX
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			8-K
<ACT>				34
<FILE-NUMBER>			001-33004
<FILM-NUMBER>			151126174
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			2635 TECHNOLOGY FOREST BLVD.
<CITY>				THE WOODLANDS
<STATE>				TX
<ZIP>				77381
<PHONE>				(281) 272-9331
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			2635 TECHNOLOGY FOREST BLVD.
<CITY>				THE WOODLANDS
<STATE>				TX
<ZIP>				77381
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		PharmaFrontiers Corp.
<DATE-CHANGED>			20051011
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		PHARMAFRONTIERS CORP
<DATE-CHANGED>			20040816
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		SPORTAN UNITED INDUSTRIES INC
<DATE-CHANGED>			19990305
</FORMER-COMPANY>
</FILER>

<DOCUMENT>
<TYPE>		8-K
<SEQUENCE>	1
<FILENAME>	opxa_8k.htm
<DESCRIPTION>	CURRENT REPORT
<TEXT>
<html>
       Show <HTML>: 439 lines (widest: 1,046 characters) - 32K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-3.1
<SEQUENCE>	2
<FILENAME>	opxa_ex31.htm
<DESCRIPTION>	CERTIFICATE OF AMENDMENT
<TEXT>
<html>
       Show <HTML>: 109 lines (widest: 2,427 characters) - 12K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-99.1
<SEQUENCE>	3
<FILENAME>	opxa_ex991.htm
<DESCRIPTION>	PRESS RELEASE
<TEXT>
<html>
       Show <HTML>: 80 lines (widest: 2,291 characters) - 11K bytes  
</TEXT>
</DOCUMENT>

</SUBMISSION>

↑Top

Filing Submission 0001354488-15-004388 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Opexa Therapeutics, Inc. – ‘8-K’ for 9/28/15

On: Monday, 9/28/15, at 7:02am ET · For: 9/28/15 · Accession #: 1354488-15-4388 · File #: 1-33004

Previous ‘8-K’: ‘8-K’ on 9/3/15 for 8/28/15 · Next: ‘8-K’ on / for 10/15/15 · Latest: ‘8-K’ on 11/20/23 for 11/17/23

Current Report — Form 8-KFiling Table of Contents

Current Report — Form 8-K
Filing Table of Contents